STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

QR Code

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN

The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.

Saved in:

Bibliographic Details
Main Author:	N. G. Gogolashvili
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	statins atorvastatin percutaneous coronary intervention perioperative myocardial infarction
Online Access:	https://www.rpcardio.online/jour/article/view/192
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

Possibilities of atorvastatin loading dose using for the prevention of perioperative myocardial damage in patients with stable coronary artery disease
by: A. S. Ragozina, et al.
Published: (2019-11-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

Percutaneous coronary interventions for ST elevation myocardial infarction in different age groups
by: I. S. Bessonov, et al.
Published: (2021-04-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction
by: A. A. Frolov, et al.
Published: (2024-01-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN ST ELEVATION MYOCARDIAL INFARCTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: O. M. Polikutina, et al.
Published: (2017-12-01)

RECENT ADVANCES IN THE APPLICATION OF HIGH DOSES OF ATORVASTATIN IN PATIENTS WITH CORONARY HEART DISEASE
by: M. V. Ezhov
Published: (2016-01-01)

Persistent ST Segment Elevation After Repeated Percutaneous Coronary Intervention: A Dressler Syndrome?
by: Eka Ginanjar, et al.
Published: (2023-01-01)

ATORVASTATIN — 20 YEARS IN THE STRUGGLE FOR LIFE
by: N. G. Gogolashvili
Published: (2018-03-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Comparative Benefits of Primary Percutaneous Coronary Intervention Versus Onsite Fibrinolytic for Patients With ST‐Segment–Elevation Myocardial Infarction: A Quasi‐Experimental Study
by: Shuduo Zhou, et al.
Published: (2025-07-01)

Rescue Fibrinolysis in STEMI Patients with Failed Primary Percutaneous Coronary Intervention at Hanoi Medical University Hospital
by: Bui Hai Hoang, et al.
Published: (2025-03-01)

Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome
by: Sh. A. Mostafa, et al.
Published: (2018-11-01)

Prediction of in-hospital mortality in patients with ST-segment elevation acute myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2023-07-01)

Controlling Nutritional Status (CONUT) score for predicting all-cause mortality in patients who underwent percutaneous coronary intervention after acute myocardial infarction: a cohort study
by: Yang Song, et al.
Published: (2025-07-01)

INTERRELATION OF TRANSCUTANEOUS CORONARY INTERVENTIONS FOR ACUTE FORMS OF CORONARY HEART DISEASE AND MORTALITY PARAMETERS IN TYUMEN REGION INHABITANTS
by: V. A. Kuznetsov, et al.
Published: (2014-06-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Late opening of occluded coronary artery in myocardial infarction patients: is it always advisable?
by: S. V. Shalaev, et al.
Published: (2007-12-01)

REGIONAL ALGORITHM OF CARE IN ST ELEVATION MYOCARDIAL INFARCTION
by: A. Yu. Vafin, et al.
Published: (2016-03-01)

Myocardial infarction in patients with HIV infection: incidence, risk factors, pathogenesis, clinical performance and treatment
by: K. V. Protasov, et al.
Published: (2024-04-01)

CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM
by: Yu. F. Salakhova, et al.
Published: (2016-01-01)

Impact of evidence-based nursing interventions on psychological status and myocardial injury in patients with myocardial infarction following percutaneous coronary intervention for reperfusion injury
by: Ni Li, et al.
Published: (2025-07-01)

Clinical case of using manual thrombus aspiration during percutaneous coronary intervention in a patient with ST-segment elevation myocardial infarction type 2
by: V. M. Mironov, et al.
Published: (2016-02-01)

Optimal management of patients with ST-segment elevation myocardial infarction with delayed admission to the percutaneous coronary intervention center (more than 12 hours)
by: S. A. Vorontsova, et al.
Published: (2021-10-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Efficiency of prognostic scores in predicting the new-onset atrial fibrillation in patients with ST-elevation myocardial infarction after percutaneous coronary intervention
by: R. L. Pak, et al.
Published: (2025-01-01)

CLINICAL OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENT IN STABLE ANGINA PATIENTS
by: D. I. Tomilova, et al.
Published: (2017-10-01)

THE RESULTS OF DELAYED ENDOVASCULAR INTERVENTION IN ST ELEVATION ACUTE MYOCARDIAL INFARCTION DUE TO THROMBOTIC OCCLUSION OF CORONARY ARTERY
by: A. V. Azarov, et al.
Published: (2017-02-01)

Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention
by: A. I. Abdrahmanova, et al.
Published: (2022-05-01)

Parameters of complete blood count and coronary lesions in predicting inhospital mortality in patients with acute ST-segment elevation myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2024-03-01)

Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)
by: O. L. Barbarash, et al.
Published: (2021-11-01)

Cystatin C-based estimated glomerular filtration rate after percutaneous coronary intervention in the prediction of inhospital mortality in acute myocardial infarction
by: K. V. Protasov, et al.
Published: (2022-01-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Dose-dependent effects of atorvastatin in the hospitalisation period of myocardial infarction
by: O. L. Barbarash, et al.
Published: (2013-06-01)

Parameters of the systemic inflammatory response and their relationship with atrial fibrillation in patients with ST-elevation myocardial infarction after percutaneous coronary intervention
by: B. I. Geltser, et al.
Published: (2025-07-01)